These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8219378)

  • 21. A comparison of two approaches to the construction of models for quantal responses to mixtures of drugs.
    Plackett RL; Hewlett PS
    Biometrics; 1967 Mar; 23(1):27-44. PubMed ID: 6050470
    [No Abstract]   [Full Text] [Related]  

  • 22. Drugs, their targets and the nature and number of drug targets.
    Imming P; Sinning C; Meyer A
    Nat Rev Drug Discov; 2006 Oct; 5(10):821-34. PubMed ID: 17016423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmaceutical industry--to whom is it accountable?
    Hayes TA
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183881
    [No Abstract]   [Full Text] [Related]  

  • 24. [The trade-mark].
    Kohlstaedt E
    Med Welt; 1969 Oct; 40():2209-11. PubMed ID: 5355668
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug nomenclature].
    Korolkovas A
    Rev Paul Med; 1973; 82(5):193-8. PubMed ID: 4792511
    [No Abstract]   [Full Text] [Related]  

  • 26. The art and science of naming drugs.
    Collier R
    CMAJ; 2014 Oct; 186(14):1053. PubMed ID: 25200754
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nomenclature of drugs and the prescription structure (concerning the article of Docent M.N. Cherniavskiĭ "Professional language of the physician and prescriptions")].
    Pershin GN
    Sov Med; 1976 Apr; (4):55-6. PubMed ID: 982144
    [No Abstract]   [Full Text] [Related]  

  • 28. Why Naunyn-Schmiedeberg's Archives of Pharmacology abandons traditional names of drug classes.
    Seifert R; Schirmer B
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1321-1325. PubMed ID: 34159409
    [No Abstract]   [Full Text] [Related]  

  • 29. Operational definitions used in recent socio-behavioral research on drugs.
    Natl Inst Drug Abuse Res Monogr Ser; 1975 Oct; (2):49-92. PubMed ID: 1233381
    [No Abstract]   [Full Text] [Related]  

  • 30. [What rules apply here and who is responsible? How drugs are distinguished from other health care products?].
    Stephan K
    Pharm Unserer Zeit; 2011 Jul; 40(4):300-4. PubMed ID: 21698627
    [No Abstract]   [Full Text] [Related]  

  • 31. Look-alike, sound-alike drug names.
    Jt Comm Perspect; 2001 Jul; 21(7):10-1. PubMed ID: 11467264
    [No Abstract]   [Full Text] [Related]  

  • 32. Patient Safety Alert. Pfizer to bar code drugs to reduce dispensing errors.
    Hosp Peer Rev; 2003 Apr; 28(4):suppl 3-4. PubMed ID: 12683098
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter: Generic versus brand names.
    J Indian Med Assoc; 1974 May; 62(10):361-3. PubMed ID: 4430845
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of generic or patent medicines in the Netherlands.
    Gebhardt DO
    J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361
    [No Abstract]   [Full Text] [Related]  

  • 35. [Classification of drugs by biochemical mechanism of action].
    Kulinskiĭ LS; Kolesnichenko LS
    Vopr Med Khim; 1998; 44(2):179-84. PubMed ID: 9634721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nontraditional areas for the use of pharmacologic preparations based on research on the molecular mechanisms of their action].
    Piruzian LA; Mikhaĭlovskiĭ EM; Dement'ev VA
    Izv Akad Nauk SSSR Biol; 1989; (6):838-42. PubMed ID: 2695546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. By any other name: ambiguity in marketing proprietary anti-infective agents.
    Berger SA
    Clin Infect Dis; 2007 Jan; 44(1):65-8. PubMed ID: 17143817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Communication of the board of directors of the Pharmacological Society and the commission drawing up directions for testing of new drugs].
    Pharmakotherapia; 1964; 2(1):195-207. PubMed ID: 5875713
    [No Abstract]   [Full Text] [Related]  

  • 39. [Classification by individual case decisions. Demarcation of cosmetics versus drug].
    Lohmüller EM
    Pharm Unserer Zeit; 2011 Jul; 40(4):351-3. PubMed ID: 21698635
    [No Abstract]   [Full Text] [Related]  

  • 40. [Considerations on drug nomenclator during the past 20 years].
    Năstasă V; Voitcu M; Pertea M
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):335-40. PubMed ID: 3685699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.